Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACT NASDAQ:CLOV NYSE:FG NYSE:LMND On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$35.72+0.9%$37.67$30.79▼$39.47$5.27B0.57406,592 shs230,823 shsCLOVClover Health Investments$2.63+2.7%$2.76$2.12▼$4.87$1.35B2.17.46 million shs6.75 million shsFGF&G Annuities & Life$28.94-0.8%$33.34$28.82▼$50.75$3.90B1.49217,952 shs191,844 shsLMNDLemonade$50.39+4.9%$53.61$17.16▼$62.00$3.72B2.242.35 million shs2.12 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact0.00%-3.78%-9.05%+0.51%-2.18%CLOVClover Health Investments0.00%-1.16%-16.34%-14.67%-37.10%FGF&G Annuities & Life0.00%-6.05%-15.66%-5.17%-33.83%LMNDLemonade0.00%-11.61%-8.30%+19.59%+177.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$35.72+0.9%$37.67$30.79▼$39.47$5.27B0.57406,592 shs230,823 shsCLOVClover Health Investments$2.63+2.7%$2.76$2.12▼$4.87$1.35B2.17.46 million shs6.75 million shsFGF&G Annuities & Life$28.94-0.8%$33.34$28.82▼$50.75$3.90B1.49217,952 shs191,844 shsLMNDLemonade$50.39+4.9%$53.61$17.16▼$62.00$3.72B2.242.35 million shs2.12 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact0.00%-3.78%-9.05%+0.51%-2.18%CLOVClover Health Investments0.00%-1.16%-16.34%-14.67%-37.10%FGF&G Annuities & Life0.00%-6.05%-15.66%-5.17%-33.83%LMNDLemonade0.00%-11.61%-8.30%+19.59%+177.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACTEnact 0.00N/AN/AN/ACLOVClover Health Investments 2.25Hold$4.3766.03% UpsideFGF&G Annuities & Life 2.00Hold$38.3332.44% UpsideLMNDLemonade 1.86Reduce$48.00-4.74% DownsideCurrent Analyst Ratings BreakdownLatest CLOV, ACT, FG, and LMND Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/10/2025LMNDLemonadePiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$60.00 ➝ $55.0010/8/2025FGF&G Annuities & LifeBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$40.00 ➝ $35.0010/8/2025ACTEnactWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (A-)10/8/2025CLOVClover Health InvestmentsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025LMNDLemonadeWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025FGF&G Annuities & LifePiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$33.0010/7/2025LMNDLemonadeMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderweight$43.00 ➝ $45.009/27/2025ACTEnactWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (A-)9/27/2025CLOVClover Health InvestmentsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025FGF&G Annuities & LifeWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)9/27/2025LMNDLemonadeWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACTEnact$1.20B4.38$4.72 per share7.57$32.53 per share1.10CLOVClover Health Investments$1.61B0.84N/AN/A$0.68 per share3.87FGF&G Annuities & Life$4.99B0.78$8.91 per share3.25$32.33 per share0.90LMNDLemonade$600.70M6.20N/AN/A$8.31 per share6.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACTEnact$688.07M$4.398.147.782.0655.35%13.61%10.42%11/5/2025 (Estimated)CLOVClover Health Investments-$43.01M-$0.08N/AN/AN/A-2.68%-12.20%-6.95%11/4/2025 (Estimated)FGF&G Annuities & Life$639M$2.4811.674.74N/A6.45%11.51%0.58%11/5/2025 (Estimated)LMNDLemonade-$202.20M-$2.83N/AN/AN/A-33.96%-36.12%-10.93%10/29/2025 (Estimated)Latest CLOV, ACT, FG, and LMND EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/5/2025Q3 2025ACTEnact$1.11N/AN/AN/A$310.26 millionN/A11/5/2025Q3 2025FGF&G Annuities & Life$1.02N/AN/AN/A$1.40 billionN/A11/4/2025Q3 2025CLOVClover Health Investments$0.02N/AN/AN/A$467.18 millionN/A10/29/2025Q3 2025LMNDLemonade-$0.70N/AN/AN/AN/AN/A8/6/2025Q2 2025FGF&G Annuities & Life$0.64$0.77+$0.13$0.26$1.35 billion$2.74 billion8/5/2025Q2 2025LMNDLemonade-$0.81-$0.60+$0.21-$0.60$160.88 million$164.10 million7/30/2025Q2 2025ACTEnact$1.11$1.15+$0.04$1.11$307.54 million$304.89 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACTEnact$0.842.35%N/A19.13%3 YearsCLOVClover Health InvestmentsN/AN/AN/AN/AN/AFGF&G Annuities & Life$0.883.04%N/A35.48%2 YearsLMNDLemonadeN/AN/AN/AN/AN/ALatest CLOV, ACT, FG, and LMND DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/7/2025FGF&G Annuities & Lifequarterly$0.222.62%9/16/20259/16/20259/30/20257/30/2025ACTEnactquarterly$0.212.44%8/18/20258/18/20259/8/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACTEnact0.141.091.09CLOVClover Health InvestmentsN/A1.801.80FGF&G Annuities & Life0.490.260.26LMNDLemonadeN/A0.890.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACTEnact18.03%CLOVClover Health Investments19.77%FGF&G Annuities & Life95.86%LMNDLemonade80.30%Insider OwnershipCompanyInsider OwnershipACTEnact0.44%CLOVClover Health Investments24.07%FGF&G Annuities & Life2.10%LMNDLemonade14.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACTEnact500147.51 million146.86 millionNot OptionableCLOVClover Health Investments680512.51 million389.15 millionOptionableFGF&G Annuities & Life1,338134.65 million131.82 millionOptionableLMNDLemonade1,23573.89 million64.65 millionOptionableCLOV, ACT, FG, and LMND HeadlinesRecent News About These CompaniesLemonade: Making Significant Strides As Growth ContinuesOctober 7, 2025 | seekingalpha.comLemonade adds PayPal's CMO to its Board of DirectorsOctober 6, 2025 | businesswire.comLemonade (LMND) Just Flashed Golden Cross Signal: Do You Buy?October 6, 2025 | zacks.comThe Best Growth Stocks to Buy With $100 Right NowOctober 1, 2025 | fool.comIs Lemonade (LMND) Stock Outpacing Its Finance Peers This Year?September 29, 2025 | zacks.com10 Hidden-Gem AI Stocks to Buy Right NowSeptember 27, 2025 | fool.comLemonade: New Reinsurance Contracts Position This Company To SoarSeptember 19, 2025 | seekingalpha.com2 Stocks Perfectly Positioned to Benefit From the $106 Trillion Great Wealth TransferSeptember 18, 2025 | fool.com1 Reason Lemonade (LMND) Is One of the Best Financial Stocks You Can Buy TodaySeptember 14, 2025 | fool.com3 No-Brainer Fintech Growth Stocks to Buy With $2,000 Right NowSeptember 13, 2025 | fool.com2 AI Stocks That Could 10X Your MoneySeptember 9, 2025 | fool.comLemonade to Present at FT Partners FinTech ConferenceSeptember 9, 2025 | businesswire.comLemonade: The Hidden Gem Of InsurTechSeptember 4, 2025 | seekingalpha.comLemonade to Attend KBW and Jefferies Investor ConferencesSeptember 2, 2025 | businesswire.com1 Reason Every Investor Should Know About Lemonade (LMND)September 2, 2025 | fool.comWhere Will Lemonade Stock Be in 5 Years?August 24, 2025 | fool.comLemonade: Growth, Momentum And Value Wrapped With AI Opportunities - BuyAugust 19, 2025 | seekingalpha.com4 Fintech Growth Stocks to Buy With $260 and Hold ForeverAugust 19, 2025 | fool.comWhere Will Lemonade Be in 1 Year?August 17, 2025 | fool.com3 Growth Stocks That Could Be Worth $1 Million in 5 YearsAugust 16, 2025 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Carmax: Now is the Time to Load Up On This Used Car StockBy Thomas Hughes | September 26, 2025Memes Are Back: Retail Investors Are Piling Into 3 Quantum StocksBy Dan Schmidt | September 29, 2025Rocket Lab’s Bullish Case Remains Intact Despite Recent OfferingBy Ryan Hasson | September 24, 2025Why Wall Street Is Betting Billions on Oklo's Nuclear VisionBy Jeffrey Neal Johnson | September 26, 2025CLOV, ACT, FG, and LMND Company DescriptionsEnact NASDAQ:ACT$35.72 +0.33 (+0.93%) Closing price 04:00 PM EasternExtended Trading$35.72 0.00 (0.00%) As of 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.Clover Health Investments NASDAQ:CLOV$2.63 +0.07 (+2.73%) Closing price 04:00 PM EasternExtended Trading$2.62 -0.01 (-0.38%) As of 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.F&G Annuities & Life NYSE:FG$28.94 -0.23 (-0.78%) Closing price 03:59 PM EasternExtended Trading$28.92 -0.02 (-0.06%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.F&G Annuities & Life, Inc. engages in the provision of fixed annuity and life insurance products. It specializes in life insurance, annuities, retirement planning and wealth transfer. The company was founded in 1959 and is headquartered in Des Moines, IA.Lemonade NYSE:LMND$50.39 +2.35 (+4.89%) Closing price 03:59 PM EasternExtended Trading$50.20 -0.19 (-0.38%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lemonade, Inc. provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, car, pet, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc. Lemonade, Inc. was incorporated in 2015 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise 2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk Applied Digital’s Shorts Got Squeezed—Now What? Levi Strauss Stock Set to Reach New Highs in 2026 Alphabet: The AI Powerhouse Driving Markets Into 2026 Is the Reddit-ChatGPT Love Affair Over? Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.